<HashMap><database>EGA</database><scores/><additional><omics_type>Genomics</omics_type><dataset_type>Illumina HiSeq 2000;</dataset_type><full_dataset_link>https://ega-archive.org/datasets/EGAD00001000984</full_dataset_link><sample_count>59</sample_count><description>EGA dataset EGAD00001000984</description><repository>EGA</repository><title>WES data</title><pubmed_abstract>Cancers are composed of populations of cells with distinct molecular and phenotypic features, a phenomenon termed intratumor heterogeneity (ITH). ITH in lung cancers has not been well studied. We applied multiregion whole-exome sequencing (WES) on 11 localized lung adenocarcinomas. All tumors showed clear evidence of ITH. On average, 76% of all mutations and 20 out of 21 known cancer gene mutations were identified in all regions of individual tumors, which suggested that single-region sequencing may be adequate to identify the majority of known cancer gene mutations in localized lung adenocarcinomas. With a median follow-up of 21 months after surgery, three patients have relapsed, and all three patients had significantly larger fractions of subclonal mutations in their primary tumors than patients without relapse. These data indicate that a larger subclonal mutation fraction may be associated with increased likelihood of postsurgical relapse in patients with localized lung adenocarcinomas.</pubmed_abstract><pubmed_title>Intratumor heterogeneity in localized lung adenocarcinomas delineated by multiregion sequencing.</pubmed_title><pubmed_authors>Zhang Jianjun J, Fujimoto Junya J, Zhang Jianhua J, Wedge David C DC, Song Xingzhi X, Zhang Jiexin J, Seth Sahil S, Chow Chi-Wan CW, Cao Yu Y, Gumbs Curtis C, Gold Kathryn A KA, Kalhor Neda N, Little Latasha L, Mahadeshwar Harshad H, Moran Cesar C, Protopopov Alexei A, Sun Huandong H, Tang Jiabin J, Wu Xifeng X, Ye Yuanqing Y, William William N WN, Lee J Jack JJ, Heymach John V JV, Hong Waun Ki WK, Swisher Stephen S, Wistuba Ignacio I II, Futreal P Andrew PA</pubmed_authors></additional><is_claimable>false</is_claimable><name>ena-DATASET-MDACC-20-08-2014-16:52:57:923-677 - samples</name><description>This is the Whole Exome Sequencing (WES) data from 59 samples from 11 patients with lung adenocarcinomas including 48 tumor samples and 11 peripheral white blood cell samples</description><dates><updated>2017-07-26 15:39:25</updated></dates><accession>EGAD00001000984</accession><cross_references><TAXONOMY>9606</TAXONOMY><pubmed>25301631</pubmed><EGA>EGAC00001000223</EGA><EGA>EGAS00001000930</EGA></cross_references></HashMap>